naa a22 4500 510763073 CHVBK 20180411083146.0 cr unu---uuuuu 180411e20130101xx s 000 0 eng 10.1007/s12094-012-0920-1 doi (NATIONALLICENCE)springer-10.1007/s12094-012-0920-1 SEOM recommendations on the structure and operation of hereditary cancer genetic counseling units (HCGCUs) [Elektronische Daten] [Enrique Lastra-Aras, Luis Robles-Díaz, Carmen Guillén-Ponce, Emilio Alba, Juan-Jesús Cruz] Introduction: Approximately 5% of all cancer cases are hereditary. Cancer genetic counseling assesses individual and family risks of cancer, conducts genetic studies, interprets results, and advises patients regarding strategies for prevention and risk reduction. Currently, many networks of hereditary cancer genetic counseling units (HCGCUs) are integrated in the medical oncology services of most Spanish hospitals, which are comprised of multidisciplinary teams and offer high-quality care for the treatment of hereditary cancer. Materials and methods: The Spanish Society of Medical Oncology (SEOM) analyzed key issues involving the integration of HCGCUs into the National Health Service. These included basic compliance issues by these units regarding their operation and organization, as well as prerequisites in quality control thereof. Results: This document describes the specific roles and clinical processes performed in HCGCUs in addition to basic services provided by molecular diagnostic laboratories. It also provides a summary on the coordination of care across different levels for patients and families with hereditary cancers. Finally, this document describes the human and material resources needed for the organization of HCGCUs. Conclusions: SEOM has been a pioneer in the creation and development of HCGCUs. This paper seeks to ensure high-quality care to individuals and families with inherited susceptibility to cancer in Spain. Federación de Sociedades Españolas de Oncología (FESEO), 2012 Hereditary cancer genetic counseling units nationallicence Recommendations nationallicence Structure nationallicence Operation nationallicence Lastra-Aras Enrique Complejo Asistencial Universitario de Burgos, Burgos, Spain aut Robles-Díaz Luis Hospital Universitario Doce de Octubre, Madrid, Spain aut Guillén-Ponce Carmen Hospital Universitario Ramón y Cajal, Madrid, Spain aut Alba Emilio Hospital Clínico Universitario Virgen de la Victoria, Málaga, Spain aut Cruz Juan-Jesús Hospital Universitario de Salamanca, Salamanca, Spain aut Clinical and Translational Oncology Springer Milan 15/1(2013-01-01), 20-25 1699-048X 15:1<20 2013 15 12094 https://doi.org/10.1007/s12094-012-0920-1 text/html Onlinezugriff via DOI 1 research-article jats NATIONALLICENCE 856 40 https://doi.org/10.1007/s12094-012-0920-1 text/html Onlinezugriff via DOI NATIONALLICENCE 700 1- Lastra-Aras Enrique Complejo Asistencial Universitario de Burgos, Burgos, Spain aut NATIONALLICENCE 700 1- Robles-Díaz Luis Hospital Universitario Doce de Octubre, Madrid, Spain aut NATIONALLICENCE 700 1- Guillén-Ponce Carmen Hospital Universitario Ramón y Cajal, Madrid, Spain aut NATIONALLICENCE 700 1- Alba Emilio Hospital Clínico Universitario Virgen de la Victoria, Málaga, Spain aut NATIONALLICENCE 700 1- Cruz Juan-Jesús Hospital Universitario de Salamanca, Salamanca, Spain aut NATIONALLICENCE 773 0- Clinical and Translational Oncology Springer Milan 15/1(2013-01-01), 20-25 1699-048X 15:1<20 2013 15 12094 Metadata rights reserved Springer special CC-BY-NC licence nationallicence BK010053 XK010053 XK010000 NATIONALLICENCE NATIONALLICENCE NL-springer